CannabisNewsBreaks

WednesdayMar 31, 2021 9:59 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Completes 1st Commercial Scale Fermentation Run of CBG

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) today announced its completion of the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG"). "We are very pleased with the yield and quality of our first commercial scale fermentation run of CBG," said Trevor Peters, Willow's president and chief executive officer. "I think it is important to take a moment to reflect on all that we have achieved in just under two years as a public company. In this time, we built a world class industrial R&D team, demonstrated proof of concept for production of cannabinoids through fermentation, attracted…

Continue Reading

TuesdayMar 30, 2021 10:35 am

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Featured in Latest Episode of Bell2Bell Podcast

Green Hygienics Holdings (OTCQB: GRYN) was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. GRYN’s CEO, Ron Loudoun, joined the latest episode, where he highlighted last year’s milestones in establishing GRYN at the company’s 824-acre farm with 400,000 square feet of greenhouse. “We cultivated 120 acres last year and it turned out beautifully. We’ve proven out our ability to grow premium product there,” Loudoun said, discussing the property’s idyllic environment for the hemp plant with nutrient-rich soil, altitude that enables night-time cooling for better growth and an…

Continue Reading

FridayMar 26, 2021 1:58 pm

CannabisNewsBreaks – RYAH Group Inc. Holds Key Distinction in Telehealth Era

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, appears ready to respond to strict data security requirements. This is an important distinction in an era where the use of telehealth solutions is exploding while securing the integrity of patient information remains critical. The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) is U.S. legislation surrounding requirements for medical providers to integrate privacy and security provisions to safeguard their patient’s medical data. Although HIPAA guidelines are temporarily relaxed during the pandemic, this flexibility is not likely to remain and it is. Therefore, it is…

Continue Reading

FridayMar 26, 2021 11:15 am

CannabisNewsBreaks – Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) Appoints New Board Member to Lead R&D

Christina Lake Cannabis (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) has appointed Salvatore Milia to its Board of Directors, effective immediately. Milia, who has invaluable experience in building large-scale information technology systems, recently created the company’s research and development committee; in his new board role, he will continue overseeing that committee and the company’s strategic plan to incorporate smart monitoring technology into its vertically integrated cannabis cultivation workflows. Milia will also focus on strengthening CLC’s crop yields and consistency while maintaining compliance with all applicable regulations. Christina Lake Cannabis recently signed a memorandum of understanding (“MOU”) with TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT)…

Continue Reading

ThursdayMar 25, 2021 2:49 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces 2nd Major DSD Expansion

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) today announced its latest partnership with Nevada Beverage Company, a Nevada-based direct-store-delivery (“DSD”) distributor. Under the agreement, Nevada Beverage will carry WTER’s full line of smooth-tasting Alkaline88 and A88 Infused flavored waters. “We are pleased to welcome Nevada Beverage Company to our growing DSD network. Nevada Beverage is a leading beverage distributor in Nevada, serving over 2,900 accounts with a territory encompassing 74% of the state population. As a best-in-class DSD provider, the partnership allows our waters to inundate another important market in the Southwest,” said Ricky Wright, president and CEO of…

Continue Reading

ThursdayMar 25, 2021 12:38 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Announces Corporate Update

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, today issued an update on its operations, including details about the recent opening of its new Nug Avenue cannabis delivery operation, located in the large and rapidly growing Los Angeles metro cannabis marketplace. “We are moving forward with our core strategic plan, as announced and discussed during 2020, which consists of expanding our end-market access as a central player in the growing California cannabis delivery marketplace and developing our cannabis production capacity to verticalize our operations in the space,” noted Jimmy Chan, CEO of Sugarmade. “The successful opening of…

Continue Reading

WednesdayMar 24, 2021 1:44 pm

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Working to Expand Test Portfolio

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which recently received European approval for its COVID-19 rapid and portable test system, has set out to increase its portfolio of tests for different diseases to help fight the current and potential pandemics. XPhyto has partnered with Germany’s 3a-diagnostics GmbH for this, according to an article on the company’s recent announcements. “The company is also working with 3a to develop a portfolio of oral biosensor screening tests that detect bacterial and viral infectious diseases ranging from influenza A to group A strep, as well as focusing on other potential pandemic biosensor tech…

Continue Reading

WednesdayMar 24, 2021 1:21 pm

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Prepares for Upcoming Retail Launch of Vapes and Gummies

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced its purchase of over 500 kg of high-potency dry cannabis flower. The purchase is in preparation for next month’s launch of retail sales of the company’s Pure Pulls vapes and Pure Chews edible gummies. Demand for these types of products is strong in the four provinces (British Columbia, Alberta, Saskatchewan and Ontario) that Pure Extracts is targeting for its retail launch, and revenue estimates associated with this shipment are just over $1,000,000. “Q2…

Continue Reading

WednesdayMar 24, 2021 12:14 pm

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Q4 and FY 2020 Financial, Operational Report

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has announced its fourth-quarter and full-year numbers for the period ended Dec. 31, 2020. In the report, Willow noted that it had filed a short form base shelf prospectus that allowed the company to make offerings of securities of up to an aggregate of $50 million. The company also completed an overnight marketed public offering for gross proceeds of $11.5 million, which was upsized by $2.0 million and included the exercise of a 15% overallotment. In addition, Willow inked a deal with…

Continue Reading

TuesdayMar 23, 2021 1:55 pm

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Results from CBD Liver Safety Study Have Been Released

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Validcare released its initial findings from an industry-sponsored, decentralized, human-safety study of hemp-derived CBD products. Validcare is coordinating the execution of the study, which HempFusion was involved with. The study may be the largest human observational, liver and human toxicology study to date. According to HempFusion’s announcement, the seven-month-long study showed no evidence of liver toxicity in any of the 839 participants enrolled in the clinical trials; the company noted that the study results are…

Continue Reading